share_log

Jefferies Maintains Buy on BELLUS Health, Raises Price Target to $21

Benzinga Real-time News ·  Sep 23, 2022 09:46

Jefferies analyst Suji Jeong maintains BELLUS Health (NASDAQ:BLU) with a Buy and raises the price target from $14 to $21.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment